Arca Biopharma | ABIO - Net Income


Arca Biopharma reported $-31.82M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Amgen USD 2.38B 556M Jun/2026
Arca Biopharma USD -31.82M 2.24M Mar/2026
Biogen USD 97.5M 222M Jun/2026
Brainstorm Cell Therapeutics USD -2.13M 21K Mar/2026
Bristol-Myers Squibb USD 3.32B 640M Jun/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 7.89B 2.34B Jun/2026
Clal Biotechnology ILS -6.17M 15.56M Dec/2022
Compugen USD -7.67M 64.51M Mar/2026
CSL USD 401M 96.5M Dec/2025
Cytokinetics USD -198.76M 7.27M Jun/2026
Daiichi Sankyo JPY 68.64B 18B Jun/2026
Gilead Sciences USD -10.5B 12.52B Jun/2026
GlaxoSmithKline GBP 435M 1.3B Jun/2026
Grifols EUR 114.37M 34.03M Dec/2025
Laboratory Of America USD 298.7M 20.9M Jun/2026
Myriad Genetics USD -7.9M 19.5M Dec/2025
Otsuka Holdings JPY 117.26B 18.92B Jun/2026
Pfizer USD -248M 2.94B Jun/2026
United Therapeutics USD 333M 58.1M Jun/2026